Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients

PURPOSE: To study ocular surface disease (OSD) changes after switching from preserved prostaglandin analogues monotherapy to preserved tafluprost and preservative-free (PF) tafluprost in primary open-angle glaucoma patients. METHODS: Glaucoma patients treated with preserved prostaglandins (except ta...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Ophthalmol
Asıl Yazarlar: Ruangvaravate, Ngamkae, Choojun, Karnthida, Srikulsasitorn, Benjawan, Chokboonpiem, Jatupol, Asanatong, Dechathon, Trakanwitthayarak, Supaporn
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2020
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548342/
https://ncbi.nlm.nih.gov/pubmed/33116362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S264984
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller